Insulet Corp (PODD)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$290.18

Buy

$296.80

arrow-up$1.53 (+0.52%)

Prices updated at 12 Dec 2025, 22:53 EST

Prices minimum 15 mins delay

Prices in USD

Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Timothy John Scannell

CEO

Ms. Ashley A. McEvoy

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

3,900

Head office

100 Nagog Park

Acton

United States

01720

+1 978 600-7000

dgordon@insulet.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer	-
Ms. Flavia H. Pease Executive Vice President, Chief Financial Officer	0.05m
Mr. Amit Guliani Group Vice President, Software Engineering and Acting Chief Technology Officer	-
Mr. Robbie Huffines Director	-
Ms. Elizabeth H. Weatherman Independent Director	0.08m
Mr. Michael R. Minogue Independent Director	0.08m
Mr. Timothy John Scannell Chairman of the Board	0.16m
Mr. John W. Kapples Senior Vice President and General Counsel	0.50m
Dr. Jessica Hopfield, PhD Director	0.06m
Mr. Timothy C. Stonesifer Independent Director	0.06m
Mr. Eric Benjamin Executive Vice President, Chief Product and Customer Experience Officer	0.54m
Ms. Lauren D. Budden Group Vice President, Chief Accounting Officer and Controller	0.41m
Dr. Wayne A.I. Frederick, M.D. Independent Director	0.08m
Mr. Dan Manea Senior Vice President and Chief Human Resources Officer	-
Dr. Luciana Borio, M.D. Independent Director	0.07m
Mr. Prem Singh Senior Vice President, Global Operations	-
Ms. Laetitia Cousin Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	8,708,355
FMR LLC	8,068,635
FMR Inc	7,569,822
Fidelity Management and Research Company	7,569,822
BlackRock Inc	6,592,652

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
10 Dec 2024	-
12 Nov 2024	-
11 Sep 2024	-
11 Sep 2024	-
11 Sep 2024	-
10 Sep 2024	-
09 Sep 2024	-
09 Sep 2024	-
30 Aug 2024	-
30 Aug 2024	-
29 Aug 2024	-
28 Aug 2024	-
28 Jun 2024	-
14 Jun 2024	-
10 Jun 2024	-
10 Jun 2024	-
04 Jun 2024	-
04 Jun 2024	-
04 Jun 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.